Drug of abuse testing is necessary to identify the presence of different drugs in person’s body through various samples such as urine, saliva, blood, hair, etc. Drug of abuse testing is important in order to offer with appropriate medical treatment to the person or to screen or monitor for the use of illegal drugs. Some of the commonly monitored drugs include:
- Amphetamine and methamphetamine
- Benzodiazepines such as diazepam, lorazepam and oxazepam
- Barbiturates such as phenobarbital, secobarbital and pentobarbital
- Opiates, such as heroin, codeine and morphine
- Phencyclidine (PCP)
The drug of abuse testing can be performed for various reasons such as medical screening, athletics testing, employment drug testing, and legal or forensic information among others. Medical screening for drugs is performed to determine what combination of drugs a person may have consumed in order to offer appropriate treatment. The effectiveness of drug depends on the response of patient’s body to the substance, quantity and combination of drug consumed, and the time it was taken. The drug of abuse testing for legal purpose aims at detecting the presence of illegitimate drug in a variety of situations. The sample collection procedures for this kind of testing are strictly controlled and documented to maintain legal chain-of-custody. Drug abuse testing at organizational level is a specific type of forensic testing. It could be done prior to the employment, or on random basis, following an accident, or in case if the employer has reasonable suspicion over an employee using illegal drugs. The drug testing is commonly performed on athletes on national and international levels with the primary focus being on doping. The use of some banned supplements or drugs promotes muscle growth and improves strength and endurance. Organizations such as World Anti-Doping Agency (WADA), International Association of Athletics Federations (IAAF) and U.S. Anti-Doping Agency (USADA) focus on monitoring and screening athletes at national, international, and Olympic level for doping. Most substances are barred in any quantity, which some, such as caffeine, are barred only when present in large amount. Some compounds, such as peptide hormones such as growth hormone, erythropoietin, and insulin-like growth factor-1 and testosterone are banned but are hard to measure as the body also produces them naturally.
||Drug of Abuse Testing Market
||2012 - 2022
||2016 - 2022
||By Product Type, By Sample, By End-Use, and By Geography
||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|Key Companies Profiled
||Siemens AG, Danaher Corporation, Shimadzu Corporation, MilliporeSigma, Drägerwerk AG & Co. KGAA, Express Diagnostics Int'l, Inc, Psychemedics Corporation, Waters Corporation, BioMerieux SA, F. Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings, Quest Diagnostics Inc, Alere Inc, Randox Laboratories Ltd, Bio-Rad Laboratories, Inc., Abbott Laboratories, Sonic Healthcare Ltd, and Thermo Fisher Scientific Inc. among others.
||Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis
10 hrs of free customization and expert consultation
The market research study on “Drug of Abuse Testing Market (Product Type: Equipment, Consumables; Sample: Urine, Saliva, Hair, Others; End-user: Hospital, Laboratory, Workplace, At Home, Others) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2012-2022” offers a detailed study on the global drug of abuse testing market entailing insights on its different market segments. The report provides insight on global market, products type, sample, end users, and geography along with discussing various factors and their impact on growth of global drug of abuse testing market. The report covers historic, current, and forecast market sizes for the mentioned market segments and sub-segments along with the country analysis for each of these market segments. The major regional markets considered under the report scope include North America, Europe, Asia-Pacific, and Rest of the World. These regions are further bifurcated into major countries in the region. The competitive analysis section in the report features high level analysis such as Porter’s five forces analysis and competitive positioning of key players based on various factors. The report also features company profiles of few leading players operating in the market and the strategies deployment by them.
The global drug of abuse testing market is growing at a significant pace owing to the increased usage of drug of abuse testing at organizational levels and increased production and trade of illicit drugs worldwide. In addition, global increase in road accidents and death rates, increase in the consumption of illegal drugs and technological advancements in drug of abuse testing further drives the market growth. At organization level, drug of abuse testing is performed in order to increase productivity, reduce absenteeism, and improve safety. According to a report from Substance Abuse and Mental Health Services Administration (SAMHSA), between 2008 and 2012, maximum illicit drug use was found in accommodations and food services industry, approximately 19.1% of full-time workers aged 18 years to 64 years were reported to have used illicit drugs in a time span of 30 days. Similarly, in 2015, maximum alcohol abuse was found in the mining industry, approximately 17.5% of full-time workers aged 18 years to 64 years were reported to have heavy alcohol drinking in a time span of 30 days. The increased utilization of drug of abuse testing at organizational levels is expected to drive the growth of the market in coming years. Further, the increased production and trafficking of illegal drugs is expected to increase the demand for drug of abuse testing. According to UN Office on Drugs and Crime (UNODC), area under opium cultivation increased from approximately 209,000 hectare in 2013 to 224,000 hectare in 2014, which is approximately 7% increase. The extent of drug seizure can be used as an indirect measure of increased trade of illicit drugs worldwide. For instance, according to UNODC, since 2002 Afghanistan, Iran and Pakistan have accounted for more than 90% opium seized across the globe, and this pattern also continued in 2013. Approximately 40 tons of cocaine was seized in 2013 in Brazil. The increase in production and trade of illicit drugs across the globe leads to increased demand for drug of abuse testing.
Asia-Pacific is expected to witness the fastest growth at a CAGR of around 10% during the forecast period from 2016 to 2022. North America held a majority share in the global drug of abuse testing market, which is driven by factors such as increased availability of drugs, higher consumption of illicit drugs and increased drug testing for legal purposes. In addition, the emphasis is being laid on work place safety, leading to increased identification and monitoring activities due to which drug of abuse testing market is also increasing. The increased cases of illicit drug trafficking in North America and growing consumption of prohibited substances has created the need for regulating and monitoring drug of abuse testing in the region. According to a publication by UN Office on Drugs and Crime (UNODC), North America had highest opioid consumption, which was around 3.8 % compared to global average of 0.7% of world’s adult population in 2013, and highest drug-related mortality was found in the U.S., which is 4.6 times the global average. According to National Institute on Drug Abuse (NIDA), approximately $700 billion are lost per annum due to loss of productivity, healthcare and crime due to illicit drug utilization in the U.S. According to Centers for Disease Control and Prevention publication, alcohol related accidents accounts for approximately one-third of all traffic related deaths, while driving under the influence of alcohol or drugs has led to approximately 1.1 million arrests in 2014 in the U.S.
The global drug of abuse testing market is segmented based on product type, sample, end user and geography. Based on product type, the market is segmented into equipment and consumables. The consumables segment was the largest and accounted for over 55% share in 2015. This segment is also expected to witness fastest growth during the forecast period. The consumables segment is further bifurcated into rapid test kit, assay kit & reagents, others. Amongst these, rapid test kit was the largest and fastest growing segment in 2015.
The player profiled in the report include Siemens AG, Danaher Corporation, Shimadzu Corporation, MilliporeSigma, Drägerwerk AG & Co. KGAA, Express Diagnostics Int'l, Inc, Psychemedics Corporation, Waters Corporation, BioMerieux SA, F. Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings, Quest Diagnostics Inc, Alere Inc, Randox Laboratories Ltd, Bio-Rad Laboratories, Inc., Abbott Laboratories, Sonic Healthcare Ltd, and Thermo Fisher Scientific Inc. among others. Mergers and acquisitions for innovation and new product development and partnership for enhancing product quality are some of the major strategies followed by leading players in this market to sustain market competition.
The global drug of abuse testing market is segmented as below:
Market By Product Type
- Immunoassay Analyzers
- Chromatography Instrument
- Breath Analyzer
- Rapid Test Kit
- Assay Kit & Reagents
Market By Sample
Market By End-User
- At Home
Market By Geography
- Rest of North America
- Rest of Europe
- Rest of Asia-Pacific